Doctors at the Mayo Clinic are readying a new form of cancer screening that they’re calling a “game-changer” when it comes to early detection.
“My dad, he was a healthy guy. He didn’t have any known risk factors for cancer,” Dr. Julia Feygin told CBS News. She was just 13 when her father died of pancreatic cancer. He was already at stage three at the time of his diagnosis and lived just nine months after learning of his diagnosis.
He was 40.
Now Feygin is helping to develop Galleri, a blood test that purports to diagnosis 50 types of cancers that can be both hard to find and extremely deadly, including pancreatic, ovarian and esophageal.
“If cancers can be detected early, we can dramatically improve patient outcomes,” Feygin said.
Feygin and her team at a company called GRAIL believe they can identify cancer through the DNA signature in blood by tracking the DNA …